PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Inflexion exits Pharmaspectra to IQVIA in $100m deal

Inflexion has sold medical data disseminator Pharmaspectra to US-listed health information company IQVIA in a deal valued at $100 million, according to a report by Unquote. The exit has generated a 25% IRR for Inflexion.

Inflexion acquired Pharmaspectra in 2019 via Enterprise Fund IV, and the deal is Inflexion’s fourth Fund IV exit following the sales of Goals Soccer Centre, Halo Technology, and Virgin Experience Days. 

Inflexion has reportedly made nine exits to date in 2022 with a combined valuation of GBP2.5 billion.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured